Kanamycin
17 brands · 15 companies · product forms
ATC: A07AA08, J01GB04, S01AA24
Opportunity snapshot
17
brands
15
companies
0
price points
0x
price spread
75
confidence %
Who competes here
Top companies by brand count — fragmented market (no dominant player) · leader share 18%
3 brands · 18%
1 brands · 6%
1 brands · 6%
1 brands · 6%
1 brands · 6%
1 brands · 6%
1 brands · 6%
1 brands · 6%
1 brands · 6%
1 brands · 6%
Brands & products on the market
Sample of 2 live products for Kanamycin — each links to its own medicine page.
Why this score
Launch attractiveness
40% supply-gap(25) + 25% price-variation(0) + 20% low-competition(62) + 15% supply-disruption(0), damped by confidence(75). Higher = more attractive, less crowded opportunity.
Market saturation
15 canonical companies and 17 brands compete (saturation pegged at 30 companies / 150 brands).
Price room
Only 0 trusted price points; variation not scored (low data).
Regulatory risk
No DRAP alerts on this molecule's brands.
Confidence
Reduced by: sparse price data.
Packaged brief for this lower opportunity?
Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.
See packaged reports All 3868 molecules